The FY2025 (Dec) proxy of Adma Biologics names 21 peer companies for pay. Among Adma Biologics and these peers, CEO pay was 3rd highest of 4 and total shareholder return was the lowest of 4.
3rd highest of 4in Adma Biologics and its pay peers, FY2025 (Dec) by CEO pay:
$7.9M$33.2M
4th highest of 4in Adma Biologics and its pay peers, FY2025 (Dec) by total shareholder return:
$106$217
Pay peer group, FY2025 (Dec) proxy
| Exelixis | ||
| Halozyme Therapeutics | ||
| Alkermes plc. | ||
| ACADIA Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| ANI Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Amphastar Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Apellis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Catalyst Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Collegium Pharmaceutical, Inc. | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Evolus, Inc. | Not disclosed | Not disclosed |
| Harmony Biosciences Holdings, Inc. | Not disclosed | Not disclosed |
| Intra-Cellular Therapies, Inc. | Not disclosed | Not disclosed |
| MannKind Corporation | Not disclosed | Not disclosed |
| MiMedx Group, Inc. | Not disclosed | Not disclosed |
| Mirum Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Sarepta Therapeutics, Inc. | Not disclosed | Not disclosed |
| Supernus Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| TG Therapeutics, Inc. | Not disclosed | Not disclosed |
| Vericel Corporation | Not disclosed | Not disclosed |
21 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.